Literature DB >> 19910378

Risk factors for epithelial ovarian cancer by histologic subtype.

Margaret A Gates1, Bernard A Rosner, Jonathan L Hecht, Shelley S Tworoger.   

Abstract

Previous epidemiologic studies suggest that the major histologic subtypes of epithelial ovarian cancer may have different risk factor profiles; however, no known prospective study has systematically examined differences in risk by subtype. The authors used Cox proportional hazards regression, stratified by histologic subtype and time period, to examine the association between ovarian cancer risk factors and incidence of serous invasive, endometrioid, and mucinous ovarian cancers in the US Nurses' Health Study (1976-2006) and Nurses' Health Study II (1989-2005). For each exposure, they calculated P-heterogeneity using a likelihood ratio test comparing models with separate estimates for the 3 subtypes versus a single estimate across subtypes. Analysis included 221,866 women and 721 cases with the histologies of interest (496 serous invasive, 139 endometrioid, 86 mucinous). In analyses of reproductive/hormonal exposures, the associations with age, duration of breastfeeding, age at natural menopause, and duration of estrogen use differed significantly by subtype (all P-heterogeneity < or =0.05). The associations with several nonreproductive exposures also appeared to vary by subtype, but only the association with smoking differed significantly (P-heterogeneity = 0.03). Results suggest that associations with several ovarian cancer risk factors vary by subtype, and these differences are consistent with known similarities between each major histologic subtype and its normal tissue counterpart.

Entities:  

Mesh:

Year:  2009        PMID: 19910378      PMCID: PMC2796984          DOI: 10.1093/aje/kwp314

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  48 in total

1.  A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

Authors:  Y Lee; A Miron; R Drapkin; M R Nucci; F Medeiros; A Saleemuddin; J Garber; C Birch; H Mou; R W Gordon; D W Cramer; F D McKeon; C P Crum
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  Risk factors for ovarian cancer histotypes.

Authors:  Francesca Chiaffarino; Fabio Parazzini; Cristina Bosetti; Silvia Franceschi; Renato Talamini; Vincenzo Canzonieri; Maurizio Montella; Valerio Ramazzotti; Silvia Franceschi; Carlo La Vecchia
Journal:  Eur J Cancer       Date:  2007-03-21       Impact factor: 9.162

Review 4.  Does smoking increase risk of ovarian cancer? A systematic review.

Authors:  Susan J Jordan; David C Whiteman; David M Purdie; Adèle C Green; Penelope M Webb
Journal:  Gynecol Oncol       Date:  2006-09-26       Impact factor: 5.482

5.  A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.

Authors:  Margaret A Gates; Shelley S Tworoger; Jonathan L Hecht; Immaculata De Vivo; Bernard Rosner; Susan E Hankinson
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

Review 6.  Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis.

Authors:  Catherine M Olsen; Christopher J Bain; Susan J Jordan; Christina M Nagle; Adèle C Green; David C Whiteman; Penelope M Webb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

7.  Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.

Authors:  Melissa A Merritt; Adèle C Green; Christina M Nagle; Penelope M Webb
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

Review 8.  My approach to and thoughts on the typing of ovarian carcinomas.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2007-08-17       Impact factor: 3.411

9.  Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.

Authors:  Marie Soegaard; Allan Jensen; Estrid Høgdall; Lise Christensen; Claus Høgdall; Jan Blaakaer; Susanne K Kjaer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

10.  A prospective study of postmenopausal hormone use and ovarian cancer risk.

Authors:  K N Danforth; S S Tworoger; J L Hecht; B A Rosner; G A Colditz; S E Hankinson
Journal:  Br J Cancer       Date:  2006-12-19       Impact factor: 7.640

View more
  76 in total

1.  Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.

Authors:  Camilla Sköld; Tone Bjørge; Anders Ekbom; Anders Engeland; Mika Gissler; Tom Grotmol; Laura Madanat-Harjuoja; Anne Gulbech Ording; Olof Stephansson; Britton Trabert; Steinar Tretli; Rebecca Troisi; Henrik Toft Sørensen; Ingrid Glimelius
Journal:  Int J Cancer       Date:  2018-07-10       Impact factor: 7.396

2.  Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.

Authors:  Kevin M Elias; S Intidhar Labidi-Galy; Allison F Vitonis; Jason L Hornick; Leona A Doyle; Michelle S Hirsch; Daniel W Cramer; Ronny Drapkin
Journal:  Gynecol Oncol       Date:  2013-12-14       Impact factor: 5.482

3.  Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Authors:  Edlira Pajenga; Tefta Rexha; Silva Çeliku; Gazmend Bejtja; Mimoza Pisha
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

4.  Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study.

Authors:  Britton Trabert; Louise A Brinton; Garnet L Anderson; Ruth M Pfeiffer; Roni T Falk; Howard D Strickler; Sarunas Sliesoraitis; Lewis H Kuller; Margery L Gass; Barbara J Fuhrman; Xia Xu; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-05       Impact factor: 4.254

5.  Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Rochelle Demsky; Susan L Neuhausen; Charmaine Kim-Sing; Nadine Tung; Susan Friedman; Leigha Senter; Jeffrey Weitzel; Beth Karlan; Pal Moller; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2014-12-18       Impact factor: 7.396

6.  In Utero Exposure to Benzo[a]pyrene Induces Ovarian Mutations at Doses That Deplete Ovarian Follicles in Mice.

Authors:  Ulrike Luderer; Matthew J Meier; Gregory W Lawson; Marc A Beal; Carole L Yauk; Francesco Marchetti
Journal:  Environ Mol Mutagen       Date:  2018-12-21       Impact factor: 3.216

7.  Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Authors:  Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen
Journal:  Am J Epidemiol       Date:  2016-04-15       Impact factor: 4.897

Review 8.  Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.

Authors:  Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen
Journal:  Am J Epidemiol       Date:  2016-12-09       Impact factor: 4.897

9.  Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.

Authors:  Britton Trabert; Sally B Coburn; Roni T Falk; JoAnn E Manson; Louise A Brinton; Margery L Gass; Lewis H Kuller; Thomas E Rohan; Ruth M Pfeiffer; Lihong Qi; Marcia L Stefanick; Nicolas Wentzensen; Garnet L Anderson; Xia Xu
Journal:  Cancer Causes Control       Date:  2019-09-21       Impact factor: 2.506

10.  Statistical methods for studying disease subtype heterogeneity.

Authors:  Molin Wang; Donna Spiegelman; Aya Kuchiba; Paul Lochhead; Sehee Kim; Andrew T Chan; Elizabeth M Poole; Rulla Tamimi; Shelley S Tworoger; Edward Giovannucci; Bernard Rosner; Shuji Ogino
Journal:  Stat Med       Date:  2015-12-01       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.